Two Sigma Investments’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-146,598
Closed -$2.07M 4312
2025
Q3
$2.07M Buy
146,598
+72,504
+98% +$1.13M ﹤0.01% 2103
2025
Q2
$1.42M Buy
74,094
+57,806
+355% +$902K ﹤0.01% 2048
2025
Q1
$180K Sell
16,288
-16,285
-50% -$194K ﹤0.01% 2874
2024
Q4
$542K Buy
32,573
+8,622
+36% +$108K ﹤0.01% 2500
2024
Q3
$243K Buy
23,951
+12,847
+116% +$382K ﹤0.01% 2749
2024
Q2
$641K Sell
11,104
-29,422
-73% -$1.44M ﹤0.01% 2238
2024
Q1
$1.35M Buy
40,526
+15,682
+63% +$794K ﹤0.01% 1760
2023
Q4
$2.02M Buy
24,844
+22,538
+977% +$1.83M ﹤0.01% 1538
2023
Q3
$376K Sell
2,306
-15,784
-87% -$3.73M ﹤0.01% 2401
2023
Q2
$5.93M Sell
18,090
-629
-3% -$192K 0.01% 852
2023
Q1
$5.17M Buy
+18,719
New +$6.87M 0.01% 890
2022
Q3
Sell
-9,229
Closed -$2.06M 2712
2022
Q2
$2.06M Buy
+9,229
New +$3.97M 0.01% 1189
2021
Q4
Sell
-2,148
Closed -$1.59M 4697
2021
Q3
$1.59M Buy
+2,148
New +$1.46M ﹤0.01% 2192
2021
Q2
Sell
-746
Closed -$608K 4432
2021
Q1
$608K Buy
+746
New +$576K ﹤0.01% 2745

Other funds holding OM

Two Sigma Investments's OM Position: Q4 2025 in Review

Two Sigma Investments sold out of Outset Medical (OM) in Q4 2025, closing a stake of 146,598 shares — an estimated $2.07M sold.

Two Sigma Investments first reported a position in OM in Q1 2021 and held it in 14 quarters. The position peaked at $5.93M in Q2 2023. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

  • Two Sigma Investments reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Investments sold 146,598 Outset Medical shares in Q4 2025, an estimated $2.07M.
  • Two Sigma Investments first reported a position in Outset Medical in Q1 2021 and held it in 14 quarters.
  • Two Sigma Investments's Outset Medical position peaked at $5.93M in Q2 2023.
  • 100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.